High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/65FC8C2C.svg?ark=w1%2F20260515%2F65FC8C2C)](https://nobleid.org/work/w1/20260515/65FC8C2C)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors